A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer
暂无分享,去创建一个
K. Kurian | A. Wyllie | I. Kunkler | C. Steel | M. Hooper | M. Mackenzie | B. Cohen | I. E. Young | M.A.F. MacKenzie | Ian Kunkler | A. Wyllie
[1] K. Kurian,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0663 Short Communication , 2022 .
[2] K. Buetow,et al. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk , 1999, British Journal of Cancer.
[3] A. Børresen-Dale,et al. A rare CYP19 (aromatase) variant may increase the risk of breast cancer. , 1998, Pharmacogenetics.
[4] S. Ueda,et al. Combined polymorphism associated with a 3-bp deletion in the 5'-flanking region of a tetrameric short tandem repeat at the CYP19 locus. , 1997, Nihon hoigaku zasshi = The Japanese journal of legal medicine.
[5] H. Sasano,et al. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.
[6] M. H. Polymeropoulos,et al. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P- 450 gene (CYP19) , 1991, Nucleic Acids Res..
[7] J. Mathis,et al. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. , 1989, The Journal of biological chemistry.
[8] C. H. Ockey,et al. Carcinoma of Male Breast in Association with the Klinefelter Syndrome , 1965, British medical journal.
[9] P. Winship,et al. POLYMORPHISM , 1945, Physics and Chemistry of Molecular Assemblies.